See related article in EMBO Molecular Medicine http://dx.doi.org/10.1002/emmm.201202273
Cerebral malaria (CM) is one of the most serious complications of Plasmodium falciparum malaria. The disease mainly affects children under five in endemic areas and is the leading cause of death. Red blood cells (RBCs) infected with P. falciparum express parasite-derived molecules on the surface, which bind to host adhesion molecules expressed on vascular endothelial cells, leading to sequestration of infected RBCs in capillaries and microvessels. Pathogenesis of CM was previously thought to derive from the occlusion of brain microvessels induced by the sequestration of infected RBCs, but recent studies show that the etiology of CM is more complex and involves host immune responses (de Souza et al, 2010) . Studies of human CM encounter difficulties due to ethical and local reasons, and histopathological examination is limited to post-mortem studies of fatal cases. Experimental cerebral malaria (ECM) in animal model is available, although there is a long-time debate regarding its usefulness as a model of human CM. Nevertheless, Plasmodium berghei ANKA (PbA) infection of susceptible mouse strains, such as C57BL/6 and CBA is the most widely used model where animals, develop the fatal disease (de Souza et al, 2010) . These mice show clinical signs of neurological symptoms such as deviation of the head, ataxia and paralysis 6-12 days after infection, when the level of parasitaemia is relatively low, and often die shortly after the onset. The disease is characterized by the accumulation of infected RBCs and leukocytes in brain blood vessels and destruction of blood-brain barrier. Thus, ECM develops in a narrow time window after PbA infection in susceptible mice, suggesting that a combination of parasite infection and host immune responses culminate in the pathogenesis of ECM.
An interesting feature of ECM is the involvement of CD8 þ T cells for its pathogenesis (Belnoue et al, 2002) . Effector molecules of CD8 þ T cells such as perforin and granzyme B are indispensable, indicating that cytolytic function of CD8 þ T cells are directly involved in the pathogenesis of ECM (Nitcheu et al, 2003) . Studies using recombinant malaria parasite expressing a model antigen demonstrated that PbA-specific CD8 þ T cells are activated by dendritic cells (DCs) cross-presenting the malaria antigen during infection (Lundie et al, 2008; Miyakoda et al, 2008) . It was also shown that vascular endothelial cells can acquire and cross-present exogenous antigens in association with MHC class I molecules (Valujskikh et al, 2002) . Based on these observations, it was proposed that brain endothelial cells incorporate infected RBCs and cross-present malaria antigens in association with MHC class I molecules (Renia et al, 2006 A. Brain microvessels incorporate malaria antigens and cross present them to specific CD8 þ T cells, which deliver cytotoxic function and damage the microvessels. B. In mice infected with ECM-non-inducing strain of malaria parasites, brain microvessels do not cross-present malaria antigen, and do not become the target of CD8 þ T cells.
Finally, an important question is whether Plasmodium-specific CD8 þ T cells are involved in the pathogenesis of human CM. It has been shown that malaria antigens can be transferred to human endothelial cells (Jambou et al, 2010) . It would be interesting to know whether Plasmodium-specific CD8 þ T cells are activated in malaria patients, and identify antigens of human malaria species that are recognized by CD8 þ T cells. Identification of parasite antigen cross-presented by brain microvessels would be a significant advance towards understanding the pathogenesis of CM. Furthermore, it would be intriguing to speculate that mechanisms similar to ECM might underlie the pathogenesis of other human neurological encephalopathy.
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